Drug intelligence / Profile preview

guipi ye

Development stage: Unknown
Lead developer: Guangdong Wannianqing
Administration: Oral

Overview

Guipi Ye is a traditional Chinese medicine (TCM) formulation developed and manufactured by Guangdong Wannianqing Pharmaceutical. It is a liquid oral formulation of the classic Guipi formula, which is traditionally used to nourish the heart, strengthen the spleen, and replenish qi and blood. The formulation is indicated for conditions resulting from heart and spleen deficiency, including palpitations, insomnia, forgetfulness, physical fatigue, and loss of appetite. It is marketed as an OTC generic product in China for the treatment of neurasthenia and chronic anemia.

Brand names: Guipi Ye
Other names: 归脾液Spleen-Nourishing Liquid

Beyond the preview

Go deeper on guipi ye.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on guipi ye.

Explore the full profile